Organising committee

ICGA Individual Members

Prof. L.S. Shashidhara
Professor, IISER Pune
Dean (R&D), Ashoka University

Mr. Ashutosh Kothari
Breast Onco-surgeon
Guy’s & St. Thomas NHS Trust, UK

Centre for Translational Cancer Research (CTCR)

CTCR is a joint initiative between PCCM, IISER, Pune and PSL to bring together clinicians and researchers. The activities of the centre will enable integration of cancer research, training, and education to effect a positive impact on translational cancer research in India.

Prashanti Cancer Care Mission (PCCM)

  • Ms. Laleh Busheri, CEO, PCCM 
  • Dr. Madhura Kulkarni (Senior Research Scientist)
  • Dr. Sneha Joshi (Senior Research Scientist)
  • Dr. Devaki A. Kelkar (Senior Research Scientist)
  • Dr. Rupa Mishra (Senior Research Scientist)

Persistent System Ltd. (PSL)

  • Dr. Keerthi Harikrishnan (Multi-Omics Research Scientist – Consultant)
  • Ms. Disha Singh (Senior Strategist, Marketing)

Indian Institute of Science Education and Research Pune (IISER Pune)

Dr. Mayurika Lahiri (Associate Professor, IISER, Pune)

The Organisers would like to thank Dr. Mohit Jolly, IISc Bangalore for his support during the conference.

Prashanti Cancer Care Mission (PCCM), Pune

PCCM is a registered, public charitable trust in Pune working with a goal of providing affordable medical treatment and rehabilitation to underprivileged cancer patients and their families. Since 2009, PCCM has also established Orchids Breast Health Center (OBHC)-a Center of Affordable Excellence for Breast Care with help from a team of oncosurgeons, radiologists, medical and radiation oncologists, clinical Scientists, physicians, nursing and para-clinical staff with patient counselors. OBHC is well equipped with advanced BC diagnostics and a chemotherapy day-care facility. The Department of Scientific and Industrial Research (DSIR), Government of India has conferred PCCM with a Scientific and Industrial Research Organisation (SIRO) status. PCCM is also a member of the National Cancer Grid of India and National Clinic-based Cancer Registry Program. PCCM Research Program is overseen by a Government of India (CDCSO)-accredited Independent Ethics Committee.

Indian Institute of Science Education and Research (IISER), Pune

IISER Pune, established in 2006 by the Ministry of Human Resource Development (MHRD) is a research intensive teaching institute. IISERs represent a unique initiative in India where teaching and education are totally integrated with state-of-the-art research nurturing both curiosity and creativity in an intellectually vibrant atmosphere of research. Biological research at IISER Pune covers a large spectrum of Biology and necessitates the availability of a wide range of instrumentation and specialist infrastructure. The biology infrastructure includes spacious research and training laboratories, “state-of-the-art” animal house, tissue culture facility as well as imaging centre, fly facility, computational resources, greenhouses, experimental field plots, and several other facilities. Institutionally, we have access to a range of spectroscopy techniques, a micro-/nano-fabrication suite, a proteomics and mass spectroscopy unit and workshop facilities. IISER Human Ethics Committee oversees translational research on IISER premises in collaboration with clinical partners.

Persistent Systems

Persistent Systems is a technology services company which builds software that drives the business of customers; enterprises and software product companies with software at the core of their digital transformation.

Indian Caner Genome Atlas (ICGA)

ICGA project is inspired by and modelled after The Cancer Genomics Atlas (TCGA) set up by the US National Cancer Institute in 2006. In this public health effort, high quality clinical meta-data of cancer patients and biospecimens (blood, cancer tissues) representing various clinical scenarios will be ethically collected from various geographical regions of India. Our goal is to characterize the genomic, transcriptomic, epigenetic, and proteomic features of Indian cancers using advanced, next-generation multi-omics technologies. The well-curated big data generated after multi-omics profiling will be analysed for correlation with clinico-pathological profiles and oncological outcomes. Such large datasets will be made available for research in the public domain in an open-source format with appropriate safeguards, documentation, bioethics, and data privacy guidelines.